Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to everyday use. In this article, we explore the world of pharmacovigilance.
Immunotherapies delivered in pill form aren’t yet the default cancer treatment. Techniques like protein painting are bringing that day closer.READ MORE
As more drug targets are discovered in the fight to treat diseases such as cancer, producing the right drugs for these targets is key to providing the best treatment and prolonging health in cancer patients.READ MORE
What do we mean by lab of the future? What innovations are required to get there? These are the key themes explored by this year's Lab of the Future Congress, summarized in this article.READ MORE
Effective treatments for post-traumatic stress disorder (PTSD) have proved extremely elusive to researchers. For some, the legalisation of cannabis could present an opportunity to develop new therapies for PTSD.We talked to Allied Corp’s CEO Calum Hughes about cannabis’s potential for PTSD therapeutics.
The Promise of In Vitro 3D Organoid Models: Meeting the ADME-Tox Testing Needs of the Pharmaceutical IndustryArticle
For many years, biologists have relied on in vitro 2D cell culture models to perform preclinical ADME-Tox assays. While these models are useful, they are limited in their translatability to drug metabolism and toxicity in humans. Recently, in vitro 3D organoid models that more closely mimic human biological systems have shown promise in supporting ADME-Tox studies in drug discovery.READ MORE
In December 2018, a diverse group of scientific researchers gathered to challenge a key issue in the science, technology, engineering and mathematics (STEM) workforce: gender bias, and sexual harassment. Now, the conclusions from the meeting have been eloquently described by 23 authors in an article published in the journal Science.READ MORE
Phenotypic screening is gaining new momentum in drug discovery with the hope that this approach will improve the success rate of drug approval. In this article we look at some of the latest screening tools and their applications.READ MORE
Maintaining robust quality control standards is a key priority for any commercial industry – but for pharmaceutical manufacturers, it can literally be a matter of life and death. The looming Brexit deadline is likely to be seen as a pivotal moment by those operating in the sector. The prospect of the UK leaving the European Union, and the jurisdiction of the EU’s unified single market for medicine regulation, is creating considerable uncertainty for drugmakers.READ MORE